Guidance on evaluation fees for human drugs and disinfectants: Overview

Health Canada has recently updated the Guidance document on fees for the review of human and disinfectant drug submissions and applications. The revised guidance takes effect on March 19, 2021.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 21:39 (UTC)
Created April 17, 2026, 21:39 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2023-02-08 00:00:00
open_canada_keywords {"fr": ["présentations et demandes de médicaments", "présentation de médicaments pour humains et de désinfectants", "document d'orientation sur les frais", "frais d'examen", "frais d'évaluation", "aperçu du document d'orientation", "orientation révisée"], "en": ["drug submissions-and-applications", "human-drugs-and-disinfectants submission", "guidance-document on fees", "fees for review", "evaluation fees", "guidance-document overview", "revised guidance"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Lignes directrices sur les frais d’évaluation des médicaments à usage humain et des désinfectants assimilés à une drogue : Aperçu
update_frequency as_needed